Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Short term Debt (2025)

Updated

Protagenic Therapeutics, Inc.new (PTIX) posted Short term Debt of $840,389 for fiscal Q3 2026 (quarter ended Dec 31, 2025), down 0.1% from the prior quarter.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Short term Debt (2025) Analysis & Trends

At the end of FY2025 (ended Mar 31, 2025), Protagenic Therapeutics, Inc.new's Short term Debt came in at $779,201.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,289.41 Bn 1,263.02 Bn 20.46 Bn
2 Johnson & Johnson 687.33 Bn 607.19 Bn 17.30 Bn
3 AbbVie 524.88 Bn 492.89 Bn 13.12 Bn
4 Merck 361.94 Bn 324.89 Bn 13.19 Bn
5 Novartis Ag 313.59 Bn 286.83 Bn -
6 Astrazeneca 287.15 Bn 260.67 Bn 13.26 Bn
7 Amgen 253.53 Bn 205.18 Bn 7.58 Bn
8 Gilead Sciences 210.46 Bn 185.57 Bn 6.73 Bn
9 Pfizer 165.39 Bn 112.74 Bn 12.56 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 840,389.00
Sep 30, 2025 841,548.00
Mar 31, 2025 779,201.00
API Access

Protagenic Therapeutics, Inc.new Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=PTIX&period=max&api_key=YOUR_API_KEY